Flulaval, Flulaval Quadrivalent Purple Book BLA 125163

BLA number
125163
Proprietary names
Flulaval, Flulaval Quadrivalent
Proper names
Influenza Vaccine
Applicant
ID Biomedical Corporation of Quebec
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Flulaval, Flulaval QuadrivalentInfluenza Vaccine351(a)45UG/.5MLInjectionIntramuscularMulti-Dose VialRxLicensed2006-10-05
002Flulaval, Flulaval QuadrivalentInfluenza Vaccine351(a)15UG/.5MLInjectionIntramuscularMulti-Dose VialDiscLicensed2009-11-10
003Flulaval, Flulaval QuadrivalentInfluenza Vaccine351(a)60UG/.5MLInjectionIntramuscularMulti-Dose VialDiscLicensed2013-08-15
004Flulaval, Flulaval QuadrivalentInfluenza Vaccine351(a)45UG/.5MLInjectionIntramuscularPre-Filled SyringeRxLicensed2013-09-27
005Flulaval, Flulaval QuadrivalentInfluenza Vaccine351(a)60UG/.5MLInjectionIntramuscularPre-Filled SyringeDiscLicensed2013-09-27

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2025-11-01U005Flulaval, Flulaval Quadrivalent351(a)DiscID Biomedical Corporation of Quebec
2024-02-01U001Flulaval, Flulaval Quadrivalent351(a)RxID Biomedical Corporation of Quebec
2024-02-01U003Flulaval, Flulaval Quadrivalent351(a)DiscID Biomedical Corporation of Quebec
2024-02-01U004Flulaval, Flulaval Quadrivalent351(a)RxID Biomedical Corporation of Quebec
2022-01-01U001Flulaval, Flulaval Quadrivalent351(a)DiscID Biomedical Corporation of Quebec
2022-01-01U002Flulaval, Flulaval Quadrivalent351(a)DiscID Biomedical Corporation of Quebec
2022-01-01U003Flulaval, Flulaval Quadrivalent351(a)RxID Biomedical Corporation of Quebec
2022-01-01U004Flulaval, Flulaval Quadrivalent351(a)DiscID Biomedical Corporation of Quebec
2022-01-01U005Flulaval, Flulaval Quadrivalent351(a)RxID Biomedical Corporation of Quebec
2021-05-01U001Flulaval, Flulaval Quadrivalent351(a)DiscID Biomedical Corporation of Quebec
2021-05-01U002Flulaval, Flulaval Quadrivalent351(a)RxID Biomedical Corporation of Quebec
2021-05-01U003Flulaval, Flulaval Quadrivalent351(a)RxID Biomedical Corporation of Quebec
2020-08-01R001Flulaval, Flulaval Quadrivalent351(a)DiscID Biomedical Corporation of Quebec
2020-08-01R002Flulaval, Flulaval Quadrivalent351(a)RxID Biomedical Corporation of Quebec
2020-08-01R003Flulaval, Flulaval Quadrivalent351(a)RxID Biomedical Corporation of Quebec

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2025-11-01005Flulaval, Flulaval Quadrivalent351(a)DiscLicensed2013-09-27
2024-02-01001Flulaval, Flulaval Quadrivalent351(a)RxLicensed2006-10-05
2024-02-01003Flulaval, Flulaval Quadrivalent351(a)DiscLicensed2013-08-15
2024-02-01004Flulaval, Flulaval Quadrivalent351(a)RxLicensed2013-09-27
2022-01-01002Flulaval, Flulaval Quadrivalent351(a)DiscLicensed2009-11-10
2022-01-01004Flulaval, Flulaval Quadrivalent351(a)DiscLicensed2013-09-27
2022-01-01005Flulaval, Flulaval Quadrivalent351(a)RxLicensed2013-09-27
2020-08-01001Flulaval, Flulaval Quadrivalent351(a)DiscLicensed2006-10-05
2020-08-01002Flulaval, Flulaval Quadrivalent351(a)RxLicensed2013-08-15
2020-08-01003Flulaval, Flulaval Quadrivalent351(a)RxLicensed2013-08-15